18 August 2021
Jenna's treatment story: Mavenclad
Jenna, 29, was diagnosed with relapsing remitting MS in 2017, just two weeks before Christmas. After three years on one of the injectable disease modifying drugs, Jenna was forced to consider changing her treatment following a relapse shortly after the birth of her baby. Here Jenna talks about why she chose to switch to Mavenclad and how she’s found the treatment so far.